Literature DB >> 23031148

Observations on degenerative changes within the optic nerve in patients with primary open glaucoma and arterial hypertension: 6-month follow-up.

Beata Krasińska1, Maciej Banach, Małgorzata Karolczak-Kulesza, Zbigniew Krasiński, Jerzy Głuszek, Andrzej Tykarski.   

Abstract

The authors aimed to determine the effect of the time of hypotensive drug administration on the progress of degenerative changes within the optic nerve in patients with hypertension and glaucoma. Two groups were included in the study: group A comprised patients-dippers taking drugs in the mornings, and group B comprised patients-nondippers taking drugs both in the mornings and in the evenings. After 6 months, group B showed significant drops in nocturnal diastolic blood pressure (BP) (month 1=73.27 mm Hg vs month 6=67.50 mm Hg), nocturnal mean BP (89.34 vs 84.65 mm Hg), and minimum diastolic BP (50.74 vs 44.03 mm Hg). Group B also showed significant reductions in nocturnal ocular perfusion pressure (43.0 vs 39.73), retinal nerve fiber layer thickness (131.31 vs 113.12 μm), and flow in the eye vessels. Taking hypotensive drugs in the evening may significantly decrease blood flow in the eye arteries, cause degenerative changes within the optic nerves, and result in greater loss in the field of vision.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23031148      PMCID: PMC8108878          DOI: 10.1111/j.1751-7176.2012.00694.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  44 in total

1.  A marked fall in nocturnal blood pressure is associated with the stage of primary open-angle glaucoma in patients with arterial hypertension.

Authors:  Beata Krasińska; Małgorzata Karolczak-Kulesza; Zbigniew Krasiński; Katarzyna Pawlaczyk-Gabriel; Arkadiusz Niklas; Jerzy Głuszek; Andrzej Tykarski
Journal:  Blood Press       Date:  2010-12-07       Impact factor: 2.835

2.  Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study.

Authors:  E O'Brien; J Murphy; A Tyndall; N Atkins; F Mee; G McCarthy; J Staessen; J Cox; K O'Malley
Journal:  J Hypertens       Date:  1991-04       Impact factor: 4.844

3.  Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment.

Authors:  J M Tielsch; J Katz; A Sommer; H A Quigley; J C Javitt
Journal:  Arch Ophthalmol       Date:  1995-02

Review 4.  Nocturnal hypotension: role in glaucoma progression.

Authors:  S L Graham; S M Drance
Journal:  Surv Ophthalmol       Date:  1999-06       Impact factor: 6.048

5.  Retrobulbar blood flow in glaucoma patients with nocturnal over-dipping in systemic blood pressure.

Authors:  D Gherghel; S Orgül; K Gugleta; J Flammer
Journal:  Am J Ophthalmol       Date:  2001-11       Impact factor: 5.258

6.  Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma.

Authors:  Takaharu Tokunaga; Kenji Kashiwagi; Toyoaki Tsumura; Kazuyuki Taguchi; Shigeo Tsukahara
Journal:  Jpn J Ophthalmol       Date:  2004 Jul-Aug       Impact factor: 2.447

7.  Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.

Authors:  Kouros Nouri-Mahdavi; Douglas Hoffman; Anne L Coleman; Gang Liu; Gang Li; Douglas Gaasterland; Joseph Caprioli
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

8.  Hypertension, diabetes, and longitudinal changes in intraocular pressure.

Authors:  Anselm Hennis; Suh-Yuh Wu; Barbara Nemesure; M Cristina Leske
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

9.  Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation.

Authors:  M Emre; S Orgül; K Gugleta; J Flammer
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

10.  Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428].

Authors:  Oliver Zeitz; Eike T Matthiessen; Juliane Reuss; Anne Wiermann; Lars Wagenfeld; Peter Galambos; Gisbert Richard; Maren Klemm
Journal:  BMC Ophthalmol       Date:  2005-04-05       Impact factor: 2.209

View more
  1 in total

1.  The influence of new beta-adrenolytics nebivolol and carvedilol on intraocular pressure and iris blood flow in rabbits.

Authors:  Dorota Szumny; Adam Szeląg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-05       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.